Sclerostin inhibition increases bone mass and bone defect regeneration in rats with type 2 diabetes mellitus

被引：0
|
作者：
Hamann, C. [1 ]
Hoehna, Y. [1 ]
Rauner, M. [1 ]
Mettelsiefen, J. [1 ]
Goettsch, C. [1 ]
Bernhardt, R. [1 ]
Guenther, K-P. [1 ]
Ominsky, M. S. [2 ]
Hofbauer, L. C. [1 ]
机构：
[1] Tech Univ Dresden, D-01062 Dresden, Germany
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
BONE | 2012年 / 50卷
关键词：
D O I：
10.1016/j.bone.2012.02.202
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S71 / S72
页数：2
相关论文
共 50 条
  • [1] Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus
    Hamann, Christine
    Rauner, Martina
    Hoehna, Yvonne
    Bernhardt, Ricardo
    Mettelsiefen, Jan
    Goettsch, Claudia
    Guenther, Klaus-Peter
    Stolina, Marina
    Han, Chun-Ya
    Asuncion, Franklin J.
    Ominsky, Michael S.
    Hofbauer, Lorenz C.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (03) : 627 - 638
  • [2] Sclerostin and bone in diabetes mellitus type 2
    Gimeno E, Jodar
    [J]. REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2012, 4 (04) : 105 - 106
  • [3] Effects of Parathyroid Hormone on Bone Mass, Bone Strength, and Bone Regeneration in Male Rats With Type 2 Diabetes Mellitus
    Hamann, Christine
    Picke, Ann-Kristin
    Campbell, Graeme M.
    Balyura, Mariya
    Rauner, Martina
    Bernhardt, Ricardo
    Huber, Gerd
    Morlock, Michael M.
    Guenther, Klaus-Peter
    Bornstein, Stefan R.
    Glueer, Claus-C.
    Ludwig, Barbara
    Hofbauer, Lorenz C.
    [J]. ENDOCRINOLOGY, 2014, 155 (04) : 1197 - 1206
  • [4] Inhibition of Sclerostin by Monoclonal Antibody Increases Bone Formation, Bone Mass, and Bone Strength in Aged Male Rats
    Li, Xiaodong
    Warmington, Kelly S.
    Niu, Qing-Tian
    Asuncion, Franklin J.
    Barrero, Mauricio
    Grisanti, Mario
    Dwyer, Denise
    Stouch, Brian
    Thway, Theingi M.
    Stolina, Marina
    Ominsky, Michael S.
    Kostenuik, Paul J.
    Simonet, William S.
    Paszty, Chris
    Ke, Hua Zhu
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (12) : 2371 - 2380
  • [5] ROLE OF SERUM SCLEROSTIN ON BONE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Garcia-Martin, Antonia
    Reyes-Garcia, Rebeca
    Rozas-Moreno, Pedro
    Morales-Santana, Sonia
    Garcia-Fontana, Beatriz
    Munoz-Torres, Manuel
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S150 - S151
  • [6] Osteoclasts in bone regeneration under type 2 diabetes mellitus
    Hu, Zhiai
    Ma, Chi
    Liang, Yongxi
    Zou, Shujuan
    Liu, Xiaohua
    [J]. ACTA BIOMATERIALIA, 2019, 84 : 402 - 413
  • [7] Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus
    Gaudio, Agostino
    Privitera, Filippo
    Battaglia, Katia
    Torrisi, Venerando
    Sidoti, Maria Helga
    Pulvirenti, Ivana
    Canzonieri, Elena
    Tringali, Giovanni
    Fiore, Carmelo Erio
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10): : 3744 - 3750
  • [8] Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2
    Christoph Wallner
    Henriette Jaurich
    Johannes Maximilian Wagner
    Mustafa Becerikli
    Kamran Harati
    Mehran Dadras
    Marcus Lehnhardt
    Björn Behr
    [J]. Scientific Reports, 7
  • [9] Bone mass and bone resorption in postmenopausal women with type 2 diabetes mellitus
    Hosoda, Hiroko
    Fukui, Michiaki
    Nakayama, Ichiko
    Asano, Mai
    Kadono, Mayuko
    Hasegawa, Goji
    Yoshikawa, Toshikazu
    Nakamura, Naoto
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (07): : 940 - 945
  • [10] Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2
    Wallner, Christoph
    Jaurich, Henriette
    Wagner, Johannes Maximilian
    Becerikli, Mustafa
    Harati, Kamran
    Dadras, Mehran
    Lehnhardt, Marcus
    Behr, Bjoern
    [J]. SCIENTIFIC REPORTS, 2017, 7
12345